CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of $95.00 billion. The enterprise value is $97.36 billion.
| Market Cap | 95.00B |
| Enterprise Value | 97.36B |
Important Dates
The next confirmed earnings date is Wednesday, July 22, 2026, before market open.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | Jun 9, 2026 |
Share Statistics
CME Group has 362.36 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 362.36M |
| Shares Outstanding | 362.36M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 91.56% |
| Float | 357.28M |
Valuation Ratios
The trailing PE ratio is 22.51 and the forward PE ratio is 21.52. CME Group's PEG ratio is 2.95.
| PE Ratio | 22.51 |
| Forward PE | 21.52 |
| PS Ratio | 14.26 |
| Forward PS | 13.65 |
| PB Ratio | 3.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.21 |
| P/OCF Ratio | 21.75 |
| PEG Ratio | 2.95 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.32, with an EV/FCF ratio of 22.49.
| EV / Earnings | 22.94 |
| EV / Sales | 14.44 |
| EV / EBITDA | 20.32 |
| EV / EBIT | 21.83 |
| EV / FCF | 22.49 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 0.86 |
| Interest Coverage | 25.45 |
Financial Efficiency
Return on equity (ROE) is 15.92% and return on invested capital (ROIC) is 12.20%.
| Return on Equity (ROE) | 15.92% |
| Return on Assets (ROA) | 1.55% |
| Return on Invested Capital (ROIC) | 12.20% |
| Return on Capital Employed (ROCE) | 12.39% |
| Weighted Average Cost of Capital (WACC) | 5.52% |
| Revenue Per Employee | $1.74M |
| Profits Per Employee | $1.10M |
| Employee Count | 3,875 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid $1.33 billion in taxes.
| Income Tax | 1.33B |
| Effective Tax Rate | 23.70% |
Stock Price Statistics
The stock price has decreased by -1.47% in the last 52 weeks. The beta is 0.24, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -1.47% |
| 50-Day Moving Average | 285.01 |
| 200-Day Moving Average | 281.90 |
| Relative Strength Index (RSI) | 40.06 |
| Average Volume (20 Days) | 3,451,650 |
Short Selling Information
The latest short interest is 4.57 million, so 1.26% of the outstanding shares have been sold short.
| Short Interest | 4.57M |
| Short Previous Month | 4.78M |
| Short % of Shares Out | 1.26% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 1.86 |
Income Statement
In the last 12 months, CME Group had revenue of $6.74 billion and earned $4.24 billion in profits. Earnings per share was $11.72.
| Revenue | 6.74B |
| Gross Profit | 6.74B |
| Operating Income | 4.46B |
| Pretax Income | 5.60B |
| Net Income | 4.24B |
| EBITDA | 4.79B |
| EBIT | 4.46B |
| Earnings Per Share (EPS) | $11.72 |
Balance Sheet
The company has $2.52 billion in cash and $3.74 billion in debt, with a net cash position of -$1.23 billion or -$3.39 per share.
| Cash & Cash Equivalents | 2.52B |
| Total Debt | 3.74B |
| Net Cash | -1.23B |
| Net Cash Per Share | -$3.39 |
| Equity (Book Value) | 26.62B |
| Book Value Per Share | 73.57 |
| Working Capital | 3.00B |
Cash Flow
In the last 12 months, operating cash flow was $4.42 billion and capital expenditures -$91.10 million, giving a free cash flow of $4.33 billion.
| Operating Cash Flow | 4.42B |
| Capital Expenditures | -91.10M |
| Depreciation & Amortization | 331.70M |
| Net Borrowing | -1.70M |
| Free Cash Flow | 4.33B |
| FCF Per Share | $11.95 |
Margins
Gross margin is 100.00%, with operating and profit margins of 66.15% and 63.32%.
| Gross Margin | 100.00% |
| Operating Margin | 66.15% |
| Pretax Margin | 82.99% |
| Profit Margin | 63.32% |
| EBITDA Margin | 71.07% |
| EBIT Margin | 66.15% |
| FCF Margin | 64.20% |
Dividends & Yields
This stock pays an annual dividend of $11.35, which amounts to a dividend yield of 4.33%.
| Dividend Per Share | $11.35 |
| Dividend Yield | 4.33% |
| Dividend Growth (YoY) | 6.13% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 95.99% |
| Buyback Yield | -0.28% |
| Shareholder Yield | 4.00% |
| Earnings Yield | 4.42% |
| FCF Yield | 4.50% |
Analyst Forecast
The average price target for CME Group is $305.47, which is 16.51% higher than the current price. The consensus rating is "Hold".
| Price Target | $305.47 |
| Price Target Difference | 16.51% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 5.99% |
| EPS Growth Forecast (3Y) | 7.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 23, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Jul 23, 2012 |
| Split Type | Forward |
| Split Ratio | 5:1 |
Scores
CME Group has an Altman Z-Score of 0.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.5 |
| Piotroski F-Score | 5 |